Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.

doi:10.1016/j.cbi.2013.02.006

Paper

DOI: 10.1016/j.cbi.2013.02.006

Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.

Published Apr 25, 2013 · S. Badole, P. P. Bagul, S. P. Mahamuni

Chemico-biological interactions

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Study Snapshot

Oral L-glutamine improves glycemic control and reduces oxidative stress in streptozotocin-nicotinamide-induced diabetic rats by increasing active GLP-1 secretion and decreasing oxidative stress.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1016/j.ejphar.2012.10.002

Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.

Cycloart-23-ene-3, 25-diol from Pongamia pinnata stem bark stimulates GLP-1 secretion, reducing plasma glucose levels and increasing insulin levels in streptozotocin-nicotinamide-induced diabetic Sprague Dawley

2013·19citations·S. Badole et al.·European journal of pharmacology

European journal of pharmacology

DOI: 10.1016/j.physbeh.2011.12.001

Nutrient detection by incretin hormone secreting cells

Incretin hormone secreting cells detect nutrient arrival in the gut, influencing postprandial insulin secretion and potentially aiding in type 2 diabetes treatment.

2012·112citations·Eleftheria Diakogiannaki et al.·Physiology & Behavior

Physiology & Behavior

DOI: 10.1016/j.bcp.2011.10.003

A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.

PKF-275-055 is a novel selective DPP-IV inhibitor with long-acting antidiabetic effect that stimulates -cell regeneration and reduces pancreatic cell apoptosis in diabetic rats.

2012·33citations·A. Akarte et al.·Biochemical pharmacology

Biochemical pharmacology

DOI: 10.1016/j.physbeh.2011.02.038

Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation

Peripheral GLP-1 can reduce meal size in chow-fed rats, but systemic increases in endogenous GLP-1 do not play a role in satiation.

2011·63citations·Mukesh Punjabi et al.·Physiology & Behavior

Physiology & Behavior

DOI: 10.3945/jn.111.139824

Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.

Glutamine reduces early postprandial glucose response and enhances late postprandial insulinemia in type 2 diabetes patients, potentially improving insulin release.

2011·92citations·D. Samocha-Bonet et al.·The Journal of nutrition

The Journal of nutrition

DOI: 10.3797/scipharm.1104-16

In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)

Olive leaf extract and glutamine effectively stimulate GLP-1 secretion in vitro and in vivo, suggesting potential as nutritional therapies for type 2 diabetes.

2011·35citations·Eamon Rafferty et al.·Scientia Pharmaceutica

Scientia Pharmaceutica

DOI: 10.1371/journal.pone.0020700

Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control

Resveratrol improves glycemic control in high-fat diet-fed diabetic mice by increasing GLP-1 secretion and modulating the enteroendocrine axis.

2011·151citations·T. Dao et al.·PLoS ONE

PLoS ONE

DOI: 10.1371/journal.pone.0018810

Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments

High concentrations of 4-hydroxytamoxifen can sensitize estrogen receptor-positive breast cancer tumorspheres to endocrine treatment, potentially improving outcomes.

2011·41citations·Ada Ao et al.·PLoS ONE

PLoS ONE

DOI: 10.1016/j.clnu.2010.07.005

Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes.

Supplemental dietary glutamine increases antioxidant potential and decreases leukocyte adhesion molecule expression and oxidative stress in mice with type 1 diabetes.

2011·28citations·Pei-Hsuan Tsai et al.·Clinical nutrition

Clinical nutrition

Citations

DOI: 10.3390/ijms25179213

In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes mellitus: A Systematic Review

In silico screening identified diverse therapeutic targets for diabetes treatment, including GLUT4, DPP-IV, and PPAR, contributing to the discovery of potential new allies.

2024·1citation·A. F. T. Gomes et al.·International Journal of Molecular Sciences

International Journal of Molecular Sciences

DOI: 10.2478/afpuc-2020-0020

Nephroprotective Effect of Coenzyme Q10 alone and in Combination with N-acetylcysteine in Diabetic Nephropathy

Coenzyme Q10 and N-acetylcysteine combined show a remarkable nephroprotective effect in diabetic nephropathy, improving renal function and reducing oxidative stress.

2021·1citation·Manoj Mahajan et al.·European Pharmaceutical Journal

European Pharmaceutical Journal

DOI: 10.1080/13813455.2020.1828478

Exogenous glutamine ameliorates diabetic nephropathy in a rat model of type 2 diabetes mellitus through its antioxidant and anti-inflammatory activities

Exogenous glutamine improves diabetic nephropathy and other complications in type 2 diabetes mellitus in rats through its antioxidant and anti-inflammatory activities.

2020·4citations·Maryam Nasri et al.·Archives of Physiology and Biochemistry

Archives of Physiology and Biochemistry

DOI: 10.1024/0300-9831/a000463

Postprandial glycemia and insulin secretion following glutamine administration: A randomized controlled trial.

Glutamine supplementation before each main meal does not effectively improve postprandial glycemic control or postprandial insulin secretion in type 2 diabetes patients.

2020·1citation·Asieh Mansour et al.·International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition

DOI: 10.2147/DMSO.S207596

GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats

Thymoquinone reduces hyperphagy in diabetic rats by increasing endogenous GLP-1 levels, improving glucose regulation and reducing obesity.

2019·3citations·Shu Ping Lee et al.·Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

DOI: 10.1016/j.mce.2019.04.013

Glutamine deprivation induces metabolic adaptations associated with beta cell dysfunction and exacerbate lipotoxicity

Low glutamine levels may contribute to beta cell dysfunction in type 2 diabetes patients, exacerbated by the saturated fatty acid palmitate.

2019·17citations·Rodrigo Carlessi et al.·Molecular and Cellular Endocrinology

Molecular and Cellular Endocrinology

DOI: 10.1016/j.bbalip.2018.06.007

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.

Oleoyl-LPI enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119, with ERK1/2 being crucial for GLP-1 secretion and CREB activation being dispensable.

2018·20citations·S. Arifin et al.·Biochimica et biophysica acta. Molecular and cell biology of lipids

Biochimica et biophysica acta. Molecular and cell biology of lipids

DOI: 10.22192/IJCRCPS.2017.04.10.004

Molecular Docking Analysis of Novel Alpha-Glucosidase enzyme Inhibitors from Siddha Formulation Pungampoo Chooranam using Computer aided drug discovery

Beta-sitosterol, Glabrin, Sterolin, and Isolonchocarpin in Pungampoo Chooranam show significant Alpha-glucosidase inhibition activity, promising anti-diabetic activity and potential for clinical management of type II diabetes.

2017·2citations·Dr. J. Nisha et al.

DOI: 10.22192/IJCRMS.2017.03.10.006

In-silico screening of Alpha Amylase Enzyme Inhibitors from Siddha Formulation Pungampoo Chooranam by Molecular docking analysis for the management of Type II Diabetes mellitus

Pinnatin, beta sitosterol, Isolonchocarpin, kanjone, pongol, and quercetin in Pungampoo Chooranam show potential anti-diabetic properties by inhibiting the enzyme alpha amylase.

2017·0citations·J. Nisha